Has Wisam Elmalik received payments from drug or device companies?

Yes. Drug and device makers reported $337,804 in general payments to Wisam Elmalik across 794 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wisam Elmalik did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wisam Elmalik come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wisam Elmalik

Neurology · Amherst, NYNPI 1942632880

Payments from drug & device makers

$337,804in general payments, 2019–2025

Across 794 payments — averaging $425.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

EMD Serono, Inc.$113K
Biogen$104K
Amgen$49K
Sanofi$35K
Novartis$14K
TG Therapeutics, Inc.$9K
plus $13K from 31 others

What the payments were for

Consulting fees$51,89818%
Speaking & faculty fees$201,63570%
Travel & lodging$18,1916%
Food & beverage$17,1246%
Education$2610%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
EMD Serono, Inc.	160	$112,689
Biogen	164	$104,500
Amgen(2 entities)	100	$48,917
Sanofi	52	$35,464
Novartis	62	$14,251
TG Therapeutics, Inc.	12	$9,228
Genentech USA, Inc.	33	$7,318
E.r. Squibb & Sons, L.L.C.	2	$1,409
MDD US Operations, LLC	35	$1,208
AbbVie(2 entities)	30	$603
Biohaven Pharmaceutical Holding Company Ltd.	41	$315
Bristol Myers Squibb	17	$268
Biohaven Pharmaceuticals, Inc.	4	$162
Neurocrine Biosciences, Inc.	9	$146
Teva Pharmaceuticals USA, Inc.	7	$128
Lundbeck LLC	1	$112
Avanir Pharmaceuticals, Inc.	5	$112
AstraZeneca	6	$109
Supernus Pharmaceuticals, Inc.	5	$92
CSL Behring	4	$91
Pfizer	5	$85
Banner Life Sciences, LLC	4	$70
Acadia Pharmaceuticals Inc	4	$70
Argenx US, Inc.	3	$61
Johnson & Johnson	4	$58
GE HealthCare	7	$55
GRT US Holding, Inc.	3	$48
Tanabe Pharma America, Inc.	3	$45
Genentech, Inc.	1	$40
Otsuka America Pharmaceutical, Inc.	2	$40
SK Life Science, Inc.	1	$24
Merz Pharmaceuticals, LLC	1	$21
Acorda Therapeutics, Inc	1	$20
Lilly USA, LLC	1	$16
Idorsia Pharmaceuticals US Inc	1	$15
Mallinckrodt Hospital Products Inc.	1	$14
Neurology Practice Consortium GPO, LLC	3	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Mavenclad$60,860
TYSABRI$49,639
UPLIZNA$47,686
AUBAGIO$34,088
TECFIDERA$17,709
Vumerity$16,659
MAYZENT$7,903
Evobrutinib$7,645
BRIUMVI$7,450
OCREVUS$6,691
GOCOVRI$592
KESIMPTA$470
NURTEC ODT$122
VYEPTI$112
DISEASE STATE$108

How this compares

$337,804 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.

See all neurology providers in New York →

Other neurology in Amherst

Laszlo MechtlerAmherst$4.3M
Bennett MyersAmherst$3.8M
Jennifer McVigeAmherst$3.1M
Nicolas SaikaliAmherst$1.8M
Christian GrommesNew York$9.9M
Ilya KisterNew York$9.5M
E DorseyNew York$8.5M
Lauren SchaffNew York$8.2M
Richard HolubAlbany$6.3M
Martin SadowskiNew York$5.4M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →